Prevalence of smoking and use of nicotine-containing products among medical students and physicians in CIS countries: a cross-sectional study
Abstract
BACKGROUND: To implement effective measures to reduce smoking and the use of novel nicotine-containing products among medical students and physicians, objective national-level data on smoking behavior are required.
AIM: This work aimed to assess the prevalence of smoking and use of nicotine-containing products among medical students and primary care physicians in the CIS.
METHODS: A cross-sectional consent-based survey was conducted. An online questionnaire administered via an electronic platform was used to assess the type of products consumed, frequency and duration of use, age of initiation, attempts to quit smoking, exposure to passive smoking, awareness of nicotine-related health risks, and availability of smoking cessation programs.
RESULTS: The study included 9222 students and 1599 physicians from five countries. The prevalence of smoking among students and physicians, respectively, was: Russia 20.3% and 17.1%; Belarus 17.0% and 18.3%; Kyrgyzstan 15.4% and 6.8%; Kazakhstan 8.2% and 12.8%; Uzbekistan 3.2% and 5.9%. Smoking prevalence among women was lower than among men in all countries (p 0.05), except among students in Belarus (p 0.05). The prevalence of nicotine-containing product use (including combined use with conventional cigarettes) did not differ between men and women among students in most countries, except in Kyrgyzstan (p 0.05). The primary risk factors for smoking among students, regardless of country, were smoking by friends and smoking by classmates or…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.